Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 3NETWORK 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Leukemia 12Lymphoma 8Sarcoma 7Leukemia, Myeloid, Acute 6Neuroblastoma 5Kidney Neoplasms 5HIV Infections 5Congenital Abnormalities 5Precancerous Conditions 4Carcinoma, Non-Small-Cell Lung 4Wilms Tumor 3Squamous Cell Carcinoma of Head and Neck 3Papillomavirus Infections 3Lymphoma, Follicular 3Lung Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Intraepithelial Lesions 2Salivary Gland Neoplasms 2Ovarian Neoplasms 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Hodgkin Disease 2Esophageal Neoplasms 2AIDS-related Kaposi sarcoma 2

Interventions

Paclitaxel 27Carboplatin 23Cisplatin 16Topotecan 8Taxes 8Docetaxel 7Gemcitabine 6Filgrastim 5Etoposide 4Doxorubicin 4Cyclophosphamide 4Psychiatric Rehabilitation 3Ifosfamide 3Chemotherapy, Adjuvant 3rubitecan 2pegfilgrastim 2paclitaxel poliglumex 2liposomal doxorubicin 2Trabectedin 2Surgical Procedures, Operative 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Irinotecan 2GEN-1 2Fenretinide 2Erlotinib Hydrochloride 2Drug Therapy 2Celecoxib 2Bevacizumab 2Amifostine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Ovarian Neoplasms × Polymerase Chain Reaction × Clear all
NCT01433224 2016-05-18

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

Children's Oncology Group

Completed
90 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT00053235 2015-06-01

Research Study in Patients With Advanced Ovarian Epithelial Cancer

GOG Foundation

Withdrawn
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡